CEACAM16

CEACAM16
Identifiers
Aliases	CEACAM16, CEAL2, DFNA4B, carcinoembryonic antigen related cell adhesion molecule 16, DFNB113, CEA cell adhesion molecule 16, tectorial membrane component
External IDs	OMIM: 614591; MGI: 2685615; HomoloGene: 19857; GeneCards: CEACAM16; OMA:CEACAM16 - orthologs
Gene location (Human)
Chr.	Chromosome 19 (human)[1]
End	44,710,718 bp[1]
Gene location (Mouse)
Chr.	Chromosome 7 (mouse)[2]
End	19,595,224 bp[2]
RNA expression pattern
	Top expressed in
	mucosa of large intestine; ; body of pancreas; ; liver; ; right lobe of liver; ; thymus; ; muscle of leg; ; pituitary gland; ; gastrocnemius muscle; ; rectum; ; anterior pituitary;
	Top expressed in
	inner ear; ; spleen; ; cerebellar cortex; ; blastocyst; ; adrenal gland; ; thymus; ; hippocampus proper; ; hypothalamus; ; placenta; ; jejunum;
	More reference expression data
	n/a
Gene ontology
Molecular function	identical protein binding;
Cellular component	stereocilium tip; extracellular region; extracellular space;
Biological process	hearing;
	Sources:Amigo / QuickGO
Orthologs
	388551
	330483
	ENSG00000213892
	ENSMUSG00000014686
	Q2WEN9
	E9QA28
	NM_001039213
	NM_001033419
	NP_001034302
	NP_001028591
	Wikidata
View/Edit Human	View/Edit Mouse

Carcinoembryonic antigen-related cell adhesion molecule 16 is encoded in the human by the CEACAM16 gene. It is a member of the carcinoembryonic antigen family, a cluster of genes on chromosome 19. CEACAM16 is a structure of the tectorial membrane involved in hearing at low and high frequencies. It is the only carcinoembryonic antigen found in the platypus.[5] The protein is expressed in mammalian outer hair cells, and mutations in this gene are associated with autosomal dominant nonsyndromic deafness.[6][7]

References

GRCh38: Ensembl release 89: ENSG00000213892 – Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000014686 – Ensembl, May 2017
"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
Kammerer R, Rüttiger L, Riesenberg R, Schäuble C, Krupar R, Kamp A, et al. (June 2012). "Loss of mammal-specific tectorial membrane component carcinoembryonic antigen cell adhesion molecule 16 (CEACAM16) leads to hearing impairment at low and high frequencies". The Journal of Biological Chemistry. 287 (26): 21584–21598. doi:10.1074/jbc.M111.320481. PMC 3381124. PMID 22544735.
Zheng J, Miller KK, Yang T, Hildebrand MS, Shearer AE, DeLuca AP, et al. (March 2011). "Carcinoembryonic antigen-related cell adhesion molecule 16 interacts with alpha-tectorin and is mutated in autosomal dominant hearing loss (DFNA4)". Proceedings of the National Academy of Sciences of the United States of America. 108 (10): 4218–4223. Bibcode:2011PNAS..108.4218Z. doi:10.1073/pnas.1005842108. PMC 3054008. PMID 21368133.
Hofrichter MA, Nanda I, Gräf J, Schröder J, Shehata-Dieler W, Vona B, Haaf T (October 2015). "A Novel de novo Mutation in CEACAM16 Associated with Postlingual Hearing Impairment". Molecular Syndromology. 6 (4): 156–163. doi:10.1159/000439576. PMC 4662267. PMID 26648831.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[refGRCh38Ensembl-1] GRCh38: Ensembl release 89: ENSG00000213892 – Ensembl, May 2017

[refGRCm38Ensembl-2] GRCm38: Ensembl release 89: ENSMUSG00000014686 – Ensembl, May 2017

[3] "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

[4] "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

[5] Kammerer R, Rüttiger L, Riesenberg R, Schäuble C, Krupar R, Kamp A, et al. (June 2012). "Loss of mammal-specific tectorial membrane component carcinoembryonic antigen cell adhesion molecule 16 (CEACAM16) leads to hearing impairment at low and high frequencies". The Journal of Biological Chemistry. 287 (26): 21584–21598. doi:10.1074/jbc.M111.320481. PMC 3381124. PMID 22544735.

[6] Zheng J, Miller KK, Yang T, Hildebrand MS, Shearer AE, DeLuca AP, et al. (March 2011). "Carcinoembryonic antigen-related cell adhesion molecule 16 interacts with alpha-tectorin and is mutated in autosomal dominant hearing loss (DFNA4)". Proceedings of the National Academy of Sciences of the United States of America. 108 (10): 4218–4223. Bibcode:2011PNAS..108.4218Z. doi:10.1073/pnas.1005842108. PMC 3054008. PMID 21368133.

[7] Hofrichter MA, Nanda I, Gräf J, Schröder J, Shehata-Dieler W, Vona B, Haaf T (October 2015). "A Novel de novo Mutation in CEACAM16 Associated with Postlingual Hearing Impairment". Molecular Syndromology. 6 (4): 156–163. doi:10.1159/000439576. PMC 4662267. PMID 26648831.